Le Lézard
Classified in: Health
Subject: MRR

Global Transplant Box Research Report 2024: Market to Reach $275+ Million by 2030, Driven by OrganOx Metra System, Collaboration and Partnerships, and Organ Donation Awareness Initiatives


DUBLIN, March 25, 2024 /PRNewswire/ -- The "Transplant Box Market Size, Share & Trends Analysis Report By Application (Kidney, Liver, Heart, Lung, Others), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global transplant box market size is anticipated to reach USD 275.27 million by 2030 and is anticipated to expand at a CAGR of 8.5%

Rising healthcare expenditure, technological advancements in organ preservation coupled with increasing demand for organ transplants, and increasing collaboration and partnerships among the industry key players are the several factors propelling the organ transplant market growth.

Moreover, regulatory approval for transplant boxes creates opportunities for market key players to grow and encourage the manufacturers to invest in R&D and manufacturing. For instance, in January 2023, U.S. FDA granted OrganOx premarket approval for its metra system, a completely automated normothermic machine perfusion (NMP) tool for transportation and preservation of donor livers intended for transplantation.

This enhances the product portfolio for the industry key players. Transplant boxes and other innovative organ preservation methods are more widely accessible due to regulatory approval. This indicates that healthcare organizations can provide novel organ transplant solutions, which benefit the patients and improves success rate for such procedures.

Raising awareness of organ donation can result in a transplant procedure that is more efficient and well-organized. Organ procurement, preservation, and distribution to patients can be carried out more effectively with a greater number of donors. Transplant boxes are crucial in these situations since they are made to preserve the viability of organs. Increased awareness of organ donation can contribute to a reduction in waiting times for transplant recipients. Quicker organ retrieval and transplantation become possible with shorter wait times.

Transplant Box Market Report Highlights

Company Profiles

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Transplant Box Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Government Initiatives To Promote Organ Donation
3.2.1.2. Rising Cases Of Multiple Organ Failure
3.2.1.3. Growing elderly population
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent Regulatory Framework
3.2.2.2. High Cost Of Organ Transplant Procedures
3.2.3. Market Opportunities Analysis
3.2.3.1. Technological Advancements
3.2.4. Market Challenge Analysis
3.2.4.1. Organ Shortage
3.3. Transplant Box Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis

Chapter 4. Transplant Box Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Transplant Box Market: Application Movement Analysis & Market Share, 2023 & 2030
4.3. Kidney
4.4. Liver
4.5. Heart
4.6. Lung
4.7. Others

Chapter 5. Transplant Box Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Transplant Box Market: Regional Movement Analysis & Market Share, 2023 & 2030

Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.2. Key Company Profiles
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Service Benchmarking
6.2.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/yubdy6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 14:35
Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow bank, announced today the launch of a new program that further expands patient access to Ossium's bone marrow. Through the HOPE (HPC Offered for...

at 14:33
Grossman Law Offices, with its principal office in Dallas, TX, extends its thoughts and support to John Hidalgo following a truck accident that occurred on April 14, 2024, around 3:50 p.m. along U.S. Highway 281 in San Antonio, TX. Mr. Hidalgo...

at 14:27
Mildred L. Oberkotter, an extraordinary individual who dedicated her life to empowering children who are deaf or hard of hearing, passed away on May 9, 2024, in her home in Moss Beach, Calif. With her unwavering commitment and visionary leadership,...

at 14:00
United Breast Cancer Foundation (UBCF) is overjoyed to celebrate the incredible success of its "Gifts of Comfort and Hope" Mattress & Pink Bag Event, held on April 27 at the welcoming Warwick Mall in Rhode Island. This heartwarming event, overflowing...

at 13:52
LensCrafters, part of EssilorLuxottica and one of the largest optical retail brands in North America, announces the opening of the company's newest store in Cicero, New York on May 10th. LensCrafters was previously located in Great Northern Mall...

at 13:45
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full Year (FY) ended 31st March 2024.     Consolidated Financial...



News published on and distributed by: